# Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

> **NCT06923592** · PHASE3 · RECRUITING · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 19200 (estimated)

## Conditions studied

- Malaria Vivax
- Malaria Falciparum
- Plasmodium Vivax
- Plasmodium Falciparum

## Interventions

- **COMBINATION_PRODUCT:** PvSeroTAT
- **DIAGNOSTIC_TEST:** Control

## Key facts

- **NCT ID:** NCT06923592
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-12
- **Primary completion:** 2027-04-28
- **Final completion:** 2027-04-28
- **Target enrollment:** 19200 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06923592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06923592, "Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06923592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*